Status:
COMPLETED
The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients
Lead Sponsor:
Sino-Swed Pharmaceutical Corporation
Conditions:
Carcinoma Surgery
Parenteral Nutrition
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate clinical safety and effect of Omega-3 fat oil emulsion on outcome in post-operative cancer patients.
Detailed Description
As an essential component of parenteral nutrition, fat emulsion has been used more than 30 years. It provides energy and essential fatty acids. Commercial fatty emulsion products mostly come from soy ...
Eligibility Criteria
Inclusion
- Post-operative male and female cancer patients
- Require post operative parenteral nutrition support at least 7 days based on nutritional risk screening(BMI 20-25)
- Sign an informed consent
Exclusion
- Diabetes Mellitus
- Abnormal fatty metabolism (TG\>200mg/dl or cholesterol\>240mg/dl )
- Renal dysfunction (Cr\>1.6mg/dl or BUN\>30mg/dl)
- Liver dysfunction (ALT\>60U/L or TBIL\>1.2mg/dl)
- Lienectomy
- Temperature\>37.5°C
- Undergoing hormone therapy
- Pregnancy
Key Trial Info
Start Date :
June 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2004
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT00292279
Start Date
June 1 2002
End Date
February 1 2004
Last Update
May 14 2008
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
People's Hospital, Beijing University
Beijing, China, 100044
2
Beijing Friendship Hospital
Beijing, China, 100050
3
Beijing Hospital
Beijing, China, 100730
4
Peking Union Medical College Hospital
Beijing, China, 100730